CSY-0073

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameCSY-0073
Drug Alias Nameanti-inflammatory macrolide (Synovo)CSY-0073CYS-0073SYD-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor α inhibitorsImmunomodulators
TargetsTumor necrosis factor α
Therapy Area/IndicationsInflammationAsthmaCystic Fibrosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSynovo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSynovo
Active IndicationsN/A
Inactive IndicationsInflammationAsthmaCystic Fibrosis +[5] 

Other Information

ATC CodeN/A
Related LinksN/A